Bielawiec P, Harasim-Symbor E, Golaszewska K, Chabowski A, Hodun K, Sztolsztener K
PLoS One. 2025; 20(3):e0315905.
PMID: 40036186
PMC: 11878926.
DOI: 10.1371/journal.pone.0315905.
Qiao K, Liu L, Chen Y, Huang Q, Chen B, Wu J
Front Nutr. 2025; 11():1525768.
PMID: 39811675
PMC: 11730078.
DOI: 10.3389/fnut.2024.1525768.
Fu C, Liu D, Liu Q, Wang X, Ma X, Pan H
Cardiovasc Diabetol. 2024; 23(1):51.
PMID: 38310324
PMC: 10838437.
DOI: 10.1186/s12933-024-02140-2.
Porat O, Kaplan M, Atlibenkin S, Hasson-Gilad D, Karban A, Zalts R
Lipids Health Dis. 2024; 23(1):30.
PMID: 38281001
PMC: 10821251.
DOI: 10.1186/s12944-024-02022-2.
Abdelfattah D, Fouad M, ElMeshad A, El-Nabarawi M, Elhabal S
Nutrients. 2024; 16(2).
PMID: 38276548
PMC: 10818276.
DOI: 10.3390/nu16020310.
Effects of remnant cholesterol on the efficacy of genotype-guided dual antiplatelet in loss-of -function carriers with minor stroke or transient ischaemic attack: a post-hoc analysis of the CHANCE-2 trial.
Wang A, Tian X, Xie X, Li H, Jing J, Lin J
EClinicalMedicine. 2023; 67:102357.
PMID: 38125963
PMC: 10730355.
DOI: 10.1016/j.eclinm.2023.102357.
Causal associations of remnant cholesterol with cardiometabolic diseases and risk factors: a mendelian randomization analysis.
Guan B, Wang A, Xu H
Cardiovasc Diabetol. 2023; 22(1):207.
PMID: 37563569
PMC: 10416527.
DOI: 10.1186/s12933-023-01927-z.
Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease.
Cheng Y, Zhang Q, Li H, Zhou G, Shi P, Zhang X
Front Endocrinol (Lausanne). 2023; 14:1098078.
PMID: 37214248
PMC: 10198261.
DOI: 10.3389/fendo.2023.1098078.
Atherogenic dyslipidemia and associated risk factors among hypertensive patients of five health facilities in Northeast Ethiopia.
Mohammed O, Alemayehu E, Ebrahim E, Fiseha M, Gedefie A, Ali A
PLoS One. 2023; 18(2):e0277185.
PMID: 36787318
PMC: 9928121.
DOI: 10.1371/journal.pone.0277185.
Medication non-adherence and therapeutic inertia independently contribute to poor disease control for cardiometabolic diseases.
Yan X, Mudiganti S, Husby H, Hudnut A, Gbotoe M, Jones J
Sci Rep. 2022; 12(1):18936.
PMID: 36344613
PMC: 9640683.
DOI: 10.1038/s41598-022-21916-8.
Remnant cholesterol is associated with cardiovascular mortality.
Zhang K, Qi X, Zhu F, Dong Q, Gou Z, Wang F
Front Cardiovasc Med. 2022; 9:984711.
PMID: 36204586
PMC: 9530659.
DOI: 10.3389/fcvm.2022.984711.
The pattern of dyslipidaemia and factors associated with elevated levels of non-HDL-cholesterol among patients with type 2 diabetes mellitus in the Ho municipality: A cross sectional study.
Lokpo S, Laryea R, Osei-Yeboah J, Owiredu W, Ephraim R, Adejumo E
Heliyon. 2022; 8(8):e10279.
PMID: 36046539
PMC: 9421188.
DOI: 10.1016/j.heliyon.2022.e10279.
Evaluation of Sampson equation for LDL-C in acute coronary syndrome patients: a Chinese population-based cohort study.
Li J, Xin Y, Li J, Meng M, Zhou L, Qiu H
Lipids Health Dis. 2022; 21(1):39.
PMID: 35436898
PMC: 9016968.
DOI: 10.1186/s12944-022-01648-4.
Elevated Remnant Cholesterol is Associated with Adverse Cardiovascular Outcomes in Patients with Acute Coronary Syndrome.
Shao Q, Yang Z, Wang Y, Li Q, Han K, Liang J
J Atheroscler Thromb. 2022; 29(12):1808-1822.
PMID: 35197421
PMC: 9881534.
DOI: 10.5551/jat.63397.
Nitrogen-doped carbon dots/Ni-MnFe-layered double hydroxides (N-CDs/Ni-MnFe-LDHs) hybrid nanomaterials as immunoassay label for low-density lipoprotein detection.
Prakobkij A, Jarujamrus P, Chunta S, Chawengkirttikul R, Keawin T, Malahom N
Mikrochim Acta. 2022; 189(2):72.
PMID: 35075569
DOI: 10.1007/s00604-022-05173-0.
Factors related to glycemic control in children and adolescents with type 1 diabetes mellitus in Isfahan, Iran.
Hashemipour M, Hovsepian S, Mozafarian N, Motaghi Z, Izadikhah E, Maracy M
J Diabetes Metab Disord. 2021; 20(2):1281-1288.
PMID: 34900779
PMC: 8630237.
DOI: 10.1007/s40200-021-00854-8.
Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease.
Wu T, Ye J, Shao C, Li F, Lin Y, Ma Q
Front Endocrinol (Lausanne). 2021; 12:691556.
PMID: 34899591
PMC: 8662313.
DOI: 10.3389/fendo.2021.691556.
A Modern Approach to Dyslipidemia.
Berberich A, Hegele R
Endocr Rev. 2021; 43(4):611-653.
PMID: 34676866
PMC: 9277652.
DOI: 10.1210/endrev/bnab037.
Discordantly normal ApoB relative to elevated LDL-C in persons with metabolic disorders: A marker of atherogenic heterogeneity.
Razavi A, Bazzano L, He J, Krousel-Wood M, Dorans K, Razavi M
Am J Prev Cardiol. 2021; 7:100190.
PMID: 34611635
PMC: 8387299.
DOI: 10.1016/j.ajpc.2021.100190.
Diet quality and cardiometabolic health in childhood: the Generation R Study.
Siddiqui N, Nguyen A, Santos S, Voortman T
Eur J Nutr. 2021; 61(2):729-736.
PMID: 34528119
PMC: 8854322.
DOI: 10.1007/s00394-021-02673-2.
